Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Other Stocks, New, 2023 Q3, Page 2

CITADEL ADVISORS LLC historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 8,173 positions, added to 6,540, reduced 6,603 and sold out of 7,821.

  • Q3 2023: Stock AGILE THERAPEUTICS INC; Country of operation —; Class COM; Shares before 0.
  • Q3 2023: Stock OKYO PHARMA LTD; Country of operation —; Class SHS NEW; Shares before 0.
  • Q3 2023: Stock IDEANOMICS INC; Country of operation —; Class COM NEW; Shares before 0.
  • Q3 2023: Stock TIVIC HEALTH SYSTEMS INC; Country of operation —; Class COM NEW; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2023AGILE THERAPEUTICS INC
CUSIP 00847L308
—COM012,825+12,825$0$30,908+$30,9082023-11-14
Q3 2023OKYO PHARMA LTD
CUSIP G6724L116
—SHS NEW015,943+15,943$0$29,495+$29,4952023-11-14
Q3 2023IDEANOMICS INC
CUSIP 45166V205
—COM NEW011,926+11,926$0$28,980+$28,9802023-11-14
Q3 2023TIVIC HEALTH SYSTEMS INC
CUSIP 888705209
—COM NEW016,701+16,701$0$28,893+$28,8932023-11-14
Q3 2023DESWELL INDS INC
CUSIP 250639101
—COM012,171+12,171$0$28,602+$28,6022023-11-14
Q3 2023INVO BIOSCIENCE INC
CUSIP 44984F401
—COM NEW036,194+36,194$0$28,600+$28,6002023-11-14
Q3 2023LQR HSE INC
CUSIP 50215C109
—COM069,875+69,875$0$28,209+$28,2092023-11-14
Q3 2023BIOVIE INC
CUSIP 09074F207
—CL A NEW08,074+8,074$0$27,532+$27,5322023-11-14
Q3 2023CHARLES & COLVARD LTD
CUSIP 159765106
—COM048,000+48,000$0$27,466+$27,4662023-11-14
Q3 2023MULTI WAYS HOLDINGS LIMITED
CUSIP G6362F108
—ORDINARY SHARES065,718+65,718$0$27,266+$27,2662023-11-14
Q3 2023ACURX PHARMACEUTICALS INC
CUSIP 00510M104
—COM018,841+18,841$0$26,943+$26,9432023-11-14
Q3 2023ATLAS ENERGY SOLUTIONS INC
CUSIP 04930R107
—COM CLASS A01,190+1,190$0$26,454+$26,4542023-11-14
Q3 2023ENSYSCE BIOSCIENCES INC
CUSIP 293602405
—COM019,113+19,113$0$26,185+$26,1852023-11-14
Q3 2023CROWN ELECTROKINETICS CORP
CUSIP 228339305
—COM058,353+58,353$0$25,967+$25,9672023-11-14
Q3 2023GOLDEN MINERALS CO
CUSIP 381119403
—COM040,048+40,048$0$25,571+$25,5712023-11-14
Q3 2023FARMMI INC
CUSIP G33277131
—SHS NEW015,921+15,921$0$25,474+$25,4742023-11-14
Q3 2023GALMED PHARMACEUTICALS LTD
CUSIP M47238122
—SHS NEW040,458+40,458$0$25,084+$25,0842023-11-14
Q3 2023TIAN RUIXIANG HLDGS LTD
CUSIP G8884K110
—CL A SHS NEW022,998+22,998$0$25,068+$25,0682023-11-14
Q3 2023A K A BRANDS HLDG CORP
CUSIP 00152K101
—COM056,704+56,704$0$24,661+$24,6612023-11-14
Q3 2023APPRECIATE HOLDINGS INC
CUSIP 03832J106
—CLASS A COM0144,346+144,346$0$24,539+$24,5392023-11-14
Q3 2023MOGO INC
CUSIP 60800C208
—COM015,143+15,143$0$23,775+$23,7752023-11-14
Q3 2023FIRST WAVE BIOPHARMA INC
CUSIP 33749P309
—COM081,859+81,859$0$23,739+$23,7392023-11-14
Q3 2023PETROS PHARMACEUTICALS INC
CUSIP 71678J209
—COM NEW014,288+14,288$0$23,718+$23,7182023-11-14
Q3 2023CHINA SXT PHARMACEUTICALS IN
CUSIP G2161P132
—SHS NEW0191,339+191,339$0$23,535+$23,5352023-11-14
Q3 2023BROOKFIELD INFRASTRUCTURE CO
CUSIP 11275Q107
—COM SB VTG SHS A0656+656$0$23,183+$23,1832023-11-14
Q3 2023USD PARTNERS LP
CUSIP 903318103
—COM UT REP LTD038,585+38,585$0$23,151+$23,1512023-11-14
Q3 2023CATALYST BIOSCIENCES INC
CUSIP 14888D208
—COM NEW047,966+47,966$0$23,134+$23,1342023-11-14
Q3 2023INNOVATE CORP
CUSIP 45784J105
—COM013,888+13,888$0$22,499+$22,4992023-11-14
Q3 2023NEUROBO PHARMACEUTICALS INC
CUSIP 64132R206
—COM NEW046,374+46,374$0$22,074+$22,0742023-11-14
Q3 2023AKANDA CORP
CUSIP 00971M205
—COM NEW040,759+40,759$0$21,602+$21,6022023-11-14
Q3 2023INNOVATIVE EYEWEAR INC
CUSIP 45791D109
—COM035,931+35,931$0$20,337+$20,3372023-11-14
Q3 2023NEUROMETRIX INC
CUSIP 641255807
—COM028,122+28,122$0$19,964+$19,9642023-11-14
Q3 2023GROVE COLLABORATIVE HOLD INC
CUSIP 39957D201
United StatesCOM CL A07,473+7,473$0$19,878+$19,8782023-11-14
Q3 2023CADRENAL THERAPEUTICS INC
CUSIP 127636108
—COM029,114+29,114$0$19,800+$19,8002023-11-14
Q3 2023ALLARITY THERAPEUTICS INC
CUSIP 016744302
—COM NEW026,215+26,215$0$19,583+$19,5832023-11-14
Q3 2023NOGIN INC
CUSIP 65528N204
—COM NEW031,615+31,615$0$17,673+$17,6732023-11-14
Q3 2023ATHERSYS INC NEW
CUSIP 04744L205
—COM NEW040,783+40,783$0$17,622+$17,6222023-11-14
Q3 2023JEFFS BRANDS LTD
CUSIP M61472102
—ORDINARY SHARES035,443+35,443$0$17,115+$17,1152023-11-14
Q3 2023BELLEROPHON THERAPEUTICS INC
CUSIP 078771300
—COM NEW042,717+42,717$0$17,087+$17,0872023-11-14
Q3 202360 DEGREES PHARMACEUTICALS I
CUSIP 83006G104
—COM022,193+22,193$0$16,423+$16,4232023-11-14
Q3 2023ITERUM THERAPEUTICS PLC
CUSIP G6333L200
—SHS NEW019,566+19,566$0$16,240+$16,2402023-11-14
Q3 2023ABVC BIOPHARMA INC
CUSIP 00091F304
United StatesCOM NEW015,591+15,591$0$16,215+$16,2152023-11-14
Q3 2023VERIFYME INC
CUSIP 92346X206
—COM NEW012,992+12,992$0$15,850+$15,8502023-11-14
Q3 2023PRESTO AUTOMATION INC
CUSIP 74113T105
—COM011,028+11,028$0$15,770+$15,7702023-11-14
Q3 2023CONTEXT THERAPEUTICS INC
CUSIP 21077P108
United StatesCOM010,438+10,438$0$15,761+$15,7612023-11-14
Q3 2023SCWORX CORP
CUSIP 78396V109
—COM076,095+76,095$0$15,660+$15,6602023-11-14
Q3 2023SATELLOGIC INC
CUSIP G7823S101
—CLASS A ORD SHS013,396+13,396$0$15,405+$15,4052023-11-14
Q3 2023NFT GAMING CO INC
CUSIP 62911P201
—COM NEW043,063+43,063$0$14,857+$14,8572023-11-14
Q3 2023LASER PHOTONICS CORP
CUSIP 51807Q100
United StatesCOM010,459+10,459$0$14,643+$14,6432023-11-14
Q3 2023VERSUS SYSTEMS INC
CUSIP 92535P881
—COM068,535+68,535$0$14,392+$14,3922023-11-14
Q3 2023ZAPP ELEC VEHS GROUP LTD
CUSIP G9889X107
—SHS018,367+18,367$0$14,378+$14,3782023-11-14
Q3 2023ADTHEORENT HOLDING COMPANY
CUSIP 00739D109
—COM010,924+10,924$0$14,092+$14,0922023-11-14
Q3 2023AMERICAN REBEL HOLDINGS INC
CUSIP 02919L307
—COM020,262+20,262$0$14,062+$14,0622023-11-14
Q3 2023TEMPEST THERAPEUTICS INC
CUSIP 87978U108
—COM044,882+44,882$0$14,048+$14,0482023-11-14
Q3 2023HEARTCORE ENTERPRISES INC
CUSIP 42240Q104
United StatesCOM013,595+13,595$0$13,595+$13,5952023-11-14
Q3 2023ARIS WATER SOLUTIONS INC
CUSIP 04041L106
—CLASS A COM01,353+1,353$0$13,503+$13,5032023-11-14
Q3 2023HEART TEST LABORATORIES INC
CUSIP 42254E104
—COM030,586+30,586$0$13,247+$13,2472023-11-14
Q3 2023PLURI INC
CUSIP 72942G104
—COM023,802+23,802$0$13,115+$13,1152023-11-14
Q3 2023VERB TECHNOLOGY CO INC
CUSIP 92337U203
—COM NEW018,270+18,270$0$12,793+$12,7932023-11-14
Q3 2023BRERA HOLDINGS PLC
CUSIP G13311108
—CLASS B ORD012,632+12,632$0$12,413+$12,4132023-11-14
Q3 2023CANOPY GROWTH CORP
CUSIP 138035100
—COM015,800+15,800$0$12,368+$12,3682023-11-14
Q3 2023EIGHTCO HOLDINGS INC
CUSIP 22890A203
—COM NEW021,818+21,818$0$12,338+$12,3382023-11-14
Q3 2023EPICQUEST EDUCATN GRP INTL L
CUSIP G3104J100
—COM014,227+14,227$0$11,995+$11,9952023-11-14
Q3 2023SPHERE 3D CORP NEW
CUSIP 84841L407
—COM NEW08,716+8,716$0$11,767+$11,7672023-11-14
Q3 2023SOCIETY PASS INC
CUSIP 83370P102
—COM030,524+30,524$0$11,569+$11,5692023-11-14
Q3 2023BIT BROTHER LIMITED
CUSIP G1144D125
—SHS NEW CL A ORD022,420+22,420$0$11,488+$11,4882023-11-14
Q3 2023REWALK ROBOTICS LTD
CUSIP M8216Q200
—SHS014,812+14,812$0$11,257+$11,2572023-11-14
Q3 2023PYROGENESIS CDA INC
CUSIP 74734T104
—COM024,257+24,257$0$10,518+$10,5182023-11-14
Q3 2023ENSERVCO CORP
CUSIP 29358Y201
—COM NEW027,296+27,296$0$10,400+$10,4002023-11-14
Q3 2023MARIS TECH LTD
CUSIP M68057104
—ORDINARY SHARES010,880+10,880$0$10,118+$10,1182023-11-14
Q3 2023LUCY SCIENTIFIC DISCOVERY IN
CUSIP 54960E104
—COM016,890+16,890$0$10,117+$10,1172023-11-14
Q3 2023BETTER THERAPEUTICS INC
CUSIP 08773T104
—COMMON STOCK026,166+26,166$0$10,095+$10,0952023-11-14
Q3 2023MARIADB PLC
CUSIP G5920M100
—ORD SHS018,668+18,668$0$8,957+$8,9572023-11-14
Q3 2023NEUROSENSE THERAPEUTICS LTD
CUSIP M74240108
—ORDINARY SHARES011,702+11,702$0$8,777+$8,7772023-11-14
Q3 2023KAIVAL BRNDS INNOVATNS GRP I
CUSIP 483104204
—COM NEW020,659+20,659$0$8,718+$8,7182023-11-14
Q3 2023UCOMMUNE INTERNATIONAL LTD
CUSIP G9449A209
—ORD SHS CL A NEW029,012+29,012$0$8,718+$8,7182023-11-14
Q3 2023YIELD10 BIOSCIENCE INC
CUSIP 98585K862
—COM026,564+26,564$0$8,678+$8,6782023-11-14
Q3 2023AINOS INC
CUSIP 00902F204
—COM NEW013,992+13,992$0$8,675+$8,6752023-11-14
Q3 2023DYNATRONICS CORP
CUSIP 268157500
—COM011,372+11,372$0$8,530+$8,5302023-11-14
Q3 2023180 LIFE SCIENCES CORP
CUSIP 68236V203
—COM NEW014,049+14,049$0$8,449+$8,4492023-11-14
Q3 2023GLUCOTRACK INC
CUSIP 45824Q507
—COM NEW032,717+32,717$0$8,343+$8,3432023-11-14
Q3 2023UPHEALTH INC
CUSIP 91532B200
—COM NEW08,416+8,416$0$8,246+$8,2462023-11-14
Q3 2023MEIWU TECHNOLOGY COMPANY LTD
CUSIP G9604C107
—ORD SHS074,929+74,929$0$8,242+$8,2422023-11-14
Q3 2023BONE BIOLOGICS CORP
CUSIP 098070402
—COM NEW011,335+11,335$0$8,049+$8,0492023-11-14
Q3 2023MEDICENNA THERAPEUTICS CORP
CUSIP 58490H107
—COM027,626+27,626$0$7,898+$7,8982023-11-14
Q3 2023INUVO INC
CUSIP 46122W204
—COM NEW033,399+33,399$0$7,147+$7,1472023-11-14
Q3 2023NEXALIN TECHNOLOGY INC
CUSIP 65345B201
United StatesCOM015,048+15,048$0$6,668+$6,6682023-11-14
Q3 2023NETCAPITAL INC
CUSIP 64113L103
—COM014,841+14,841$0$6,085+$6,0852023-11-14
Q3 2023COMERA LIFE SCIENCES HLDGS I
CUSIP 20037C108
—COM017,458+17,458$0$5,569+$5,5692023-11-14
Q3 2023VIRAX BIOLABS GROUP LTD
CUSIP G9495L109
—ORD SHS016,362+16,362$0$5,318+$5,3182023-11-14
Q3 2023INTEGRATED MEDIA TECHNLOGY L
CUSIP Q49376108
—SHS024,143+24,143$0$4,698+$4,6982023-11-14
Q3 2023TERRAN ORBITAL CORPORATION
CUSIP 88105P103
—COM05,607+5,607$0$4,667+$4,6672023-11-14
Q3 2023TENAX THERAPEUTICS INC
CUSIP 88032L506
—COM015,033+15,033$0$4,432+$4,4322023-11-14
Q3 2023UNIQUE FABRICATING INC
CUSIP 90915J103
—COM018,820+18,820$0$4,298+$4,2982023-11-14
Q3 2023GENPREX INC
CUSIP 372446104
—COM010,828+10,828$0$4,276+$4,2762023-11-14
Q3 2023XWELL INC
CUSIP 98420U802
United StatesCOM NEW01,871+1,871$0$4,210+$4,2102023-11-14
Q3 2023VERTICAL AEROSPACE LTD
CUSIP G9471C107
—ORD SHS02,618+2,618$0$3,089+$3,0892023-11-14
Q3 2023OUTLOOK THERAPEUTICS INC
CUSIP 69012T206
—COM NEW013,517+13,517$0$2,987+$2,9872023-11-14
Q3 2023HOOKIPA PHARMA INC
CUSIP 43906K100
—COM04,739+4,739$0$2,919+$2,9192023-11-14
Q3 2023IMPERIAL PETE INC
CUSIP Y3894J187
—COM NEW01,700+1,700$0$2,686+$2,6862023-11-14